Crohn's disease is a type of inflammatory bowel disease, and the causes are unclear. Now resarch has shown it may be related ...

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress ...

A small U.S. study explored whether immune markers seen in many long COVID sufferers are also present in people with ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were still alive, most without disease ...

His research shows molecular changes in brain cells when a person has Multiple sclerosis (MS). But it is still unclear whether they contribute to - or ...

Stagwell Inc. (the "Company") announced today the grant of equity inducement awards. Effective March 7, 2025, the Company granted a total of 69,170 restricted stock units to nine new employees. Each ...

D Boral Capital initiates Buy on Tevogen Bio citing its scalable T-cell therapies and upcoming clinical readouts, with a $10 price target.

WOW! Internet, TV & Phone , a leading broadband provider in the United States, announced today it will host a webcast and conference call on Friday, March 14, 2025 at 8:00 a.m. ET to discuss financial ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

Atara Biotherapeutics Inc ( ($ATRA) ) has released its Q4 earnings. Here is a breakdown of the information Atara Biotherapeutics Inc presented to ...

Boeing, Citigroup, General Electric, Moderna, Lockheed Martin, Celestica, and Analog Devices are the seven Defense stocks to watch today, according to MarketBeat’s stock screener tool. Defense stocks ...